| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A cross-market cost comparison of erlotinib versus pemetrexed for first-line maintenance treatment of patients with locally advanced or metastatic non-small-cell lung cancer
|
Nuijten, Mark J.C.
|
|
2012
|
76 |
3 |
p. 465-471
7 p.
|
artikel
|
| 2 |
A meta-analysis of paclitaxel-based chemotherapies administered once every week compared with once every 3 weeks first-line treatment of advanced non-small-cell lung cancer
|
Gao, Guanghui
|
|
2012
|
76 |
3 |
p. 380-386
7 p.
|
artikel
|
| 3 |
An ectopic ACTH-producing small cell lung carcinoma associated with enhanced corticosteroid biosynthesis in the peritumoral areas of adrenal metastasis
|
Satoh, Hironori
|
|
2012
|
76 |
3 |
p. 486-490
5 p.
|
artikel
|
| 4 |
A specific diplotype defined by PPP1R13L rs1970764, CD3EAP rs967591 and ERCC1 rs11615 and lung cancer risk in a Chinese population
|
Yin, Jiaoyang
|
|
2012
|
76 |
3 |
p. 286-291
6 p.
|
artikel
|
| 5 |
Benefits and risks of using erythropoiesis-stimulating agents (ESAs) in lung cancer patients: Study-level and patient-level meta-analyses
|
Vansteenkiste, Johan
|
|
2012
|
76 |
3 |
p. 478-485
8 p.
|
artikel
|
| 6 |
Biomarkers for small cell lung cancer: Neuroendocrine, epithelial and circulating tumour cells
|
Stovold, Rachel
|
|
2012
|
76 |
3 |
p. 263-268
6 p.
|
artikel
|
| 7 |
Challenges scoring radiation pneumonitis in patients irradiated for lung cancer
|
Yirmibesoglu, Eda
|
|
2012
|
76 |
3 |
p. 350-353
4 p.
|
artikel
|
| 8 |
Characteristics of lung cancer in women: Importance of hormonal and growth factors
|
Rouquette, Isabelle
|
|
2012
|
76 |
3 |
p. 280-285
6 p.
|
artikel
|
| 9 |
Characterization of the immunophenotype of the tumor budding and its prognostic implications in squamous cell carcinoma of the lung
|
Taira, Tetsuhiko
|
|
2012
|
76 |
3 |
p. 423-430
8 p.
|
artikel
|
| 10 |
CHD5, a tumor suppressor that is epigenetically silenced in lung cancer
|
Zhao, Rui
|
|
2012
|
76 |
3 |
p. 324-331
8 p.
|
artikel
|
| 11 |
Clinical outcomes of leptomeningeal metastasis in patients with non-small cell lung cancer in the modern chemotherapy era
|
Park, Jin Hyun
|
|
2012
|
76 |
3 |
p. 387-392
6 p.
|
artikel
|
| 12 |
Clinicopathologic implication of ALK rearrangement in surgically resected lung cancer
|
Paik, Jin Ho
|
|
2012
|
76 |
3 |
p. 403-409
7 p.
|
artikel
|
| 13 |
Contents
|
|
|
2012
|
76 |
3 |
p. v-vii
nvt p.
|
artikel
|
| 14 |
Conversion from the “oncogene addiction” to “drug addiction” by intensive inhibition of the EGFR and MET in lung cancer with activating EGFR mutation
|
Suda, Kenichi
|
|
2012
|
76 |
3 |
p. 292-299
8 p.
|
artikel
|
| 15 |
Correlations between serial pro-gastrin-releasing peptide and neuron-specific enolase levels, and the radiological response to treatment and survival of patients with small-cell lung cancer
|
Ono, Akira
|
|
2012
|
76 |
3 |
p. 439-444
6 p.
|
artikel
|
| 16 |
Differences in metabolism between adeno- and squamous cell non-small cell lung carcinomas: Spatial distribution and prognostic value of GLUT1 and MCT4
|
Meijer, Tineke W.H.
|
|
2012
|
76 |
3 |
p. 316-323
8 p.
|
artikel
|
| 17 |
Differential effect of age on survival in advanced NSCLC in women versus men: Analysis of recent Eastern Cooperative Oncology Group (ECOG) studies, with and without bevacizumab
|
Wakelee, H.A.
|
|
2012
|
76 |
3 |
p. 410-415
6 p.
|
artikel
|
| 18 |
Editorial Board
|
|
|
2012
|
76 |
3 |
p. iii-
1 p.
|
artikel
|
| 19 |
Erlotinib or best supportive care for third-line treatment of advanced non-small-cell lung cancer: A real-world cost-effectiveness analysis
|
Cromwell, Ian
|
|
2012
|
76 |
3 |
p. 472-477
6 p.
|
artikel
|
| 20 |
Estimation of renal function in lung cancer patients
|
Trobec, Katja
|
|
2012
|
76 |
3 |
p. 397-402
6 p.
|
artikel
|
| 21 |
FATS expression is associated with cisplatin sensitivity in non small cell lung cancer
|
Tian, Yin
|
|
2012
|
76 |
3 |
p. 416-422
7 p.
|
artikel
|
| 22 |
Higher expression of EphA2 and ephrin-A1 is related to favorable clinicopathological features in pathological stage I non-small cell lung carcinoma
|
Ishikawa, Masashi
|
|
2012
|
76 |
3 |
p. 431-438
8 p.
|
artikel
|
| 23 |
Histologic subtypes, immunohistochemistry, FISH or molecular screening for the accurate diagnosis of ALK-rearrangement in lung cancer: A comprehensive study of Caucasian non-smokers
|
Just, Pierre-Alexandre
|
|
2012
|
76 |
3 |
p. 309-315
7 p.
|
artikel
|
| 24 |
History of tuberculosis as an independent prognostic factor for lung cancer survival
|
Heuvers, Marlies E.
|
|
2012
|
76 |
3 |
p. 452-456
5 p.
|
artikel
|
| 25 |
Hypereosinophilia driven by GM-CSF in large-cell carcinoma of the lung
|
Lammel, Verena
|
|
2012
|
76 |
3 |
p. 493-495
3 p.
|
artikel
|
| 26 |
Inhibitory effect of riccardin D on growth of human non-small cell lung cancer: In vitro and in vivo studies
|
Xue, Xia
|
|
2012
|
76 |
3 |
p. 300-308
9 p.
|
artikel
|
| 27 |
Intravitreal administration of bevacizumab in the treatment of choroidal metastasis in a patient with erlotinib-failed pulmonary adenocarcinoma
|
Lai, Chun-Liang
|
|
2012
|
76 |
3 |
p. 496-498
3 p.
|
artikel
|
| 28 |
Maintenance treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology
|
Gridelli, Cesare
|
|
2012
|
76 |
3 |
p. 269-279
11 p.
|
artikel
|
| 29 |
MO19390 (SAiL): Bleeding events in a phase IV study of first-line bevacizumab with chemotherapy in patients with advanced non-squamous NSCLC
|
Dansin, Eric
|
|
2012
|
76 |
3 |
p. 373-379
7 p.
|
artikel
|
| 30 |
Pemetrexed as a possible cause of severe rhabdomyolysis in the treatment of lung cancer
|
Huang, Ming-Shyan
|
|
2012
|
76 |
3 |
p. 491-492
2 p.
|
artikel
|
| 31 |
Prognostic impact of education level of patients with advanced non-small cell lung cancer enrolled in clinical trials
|
Di Maio, Massimo
|
|
2012
|
76 |
3 |
p. 457-464
8 p.
|
artikel
|
| 32 |
Prospective phase II trial of a combination of gemcitabine and UFT as first-line treatment in elderly patients with advanced non-small cell lung cancer
|
Baek, Jin Ho
|
|
2012
|
76 |
3 |
p. 368-372
5 p.
|
artikel
|
| 33 |
Randomized phase II study of first-line carboplatin-paclitaxel with or without bevacizumab in Japanese patients with advanced non-squamous non-small-cell lung cancer
|
Niho, Seiji
|
|
2012
|
76 |
3 |
p. 362-367
6 p.
|
artikel
|
| 34 |
3rd line Erlotinib for lung cancer in Asia may be as cost-effective as in the Western world
|
Lin, Ching-Chan
|
|
2012
|
76 |
3 |
p. 499-500
2 p.
|
artikel
|
| 35 |
Small-cell carcinoma of the lung detected by CT screening: Stage distribution and curability
|
Austin, John H.M.
|
|
2012
|
76 |
3 |
p. 339-343
5 p.
|
artikel
|
| 36 |
Soluble epidermal growth factor receptor isoforms in non-small cell lung cancer tissue and in blood
|
Maramotti, Sally
|
|
2012
|
76 |
3 |
p. 332-338
7 p.
|
artikel
|
| 37 |
Stromal CD4/CD25 positive T-cells are a strong and independent prognostic factor in non-small cell lung cancer patients, especially with adenocarcinomas
|
Kayser, Gian
|
|
2012
|
76 |
3 |
p. 445-451
7 p.
|
artikel
|
| 38 |
The management impact of clinically significant incidental lesions detected on staging FDG PET-CT in patients with non-small cell lung cancer (NSCLC): An analysis of 649 cases
|
Lin, Michael
|
|
2012
|
76 |
3 |
p. 344-349
6 p.
|
artikel
|
| 39 |
Trabectedin in patients with advanced non-small-cell lung cancer (NSCLC) with XPG and/or ERCC1 overexpression and BRCA1 underexpression and pretreated with platinum
|
Massuti, Bartomeu
|
|
2012
|
76 |
3 |
p. 354-361
8 p.
|
artikel
|
| 40 |
Vatalanib in malignant mesothelioma: A phase II trial by the Cancer and Leukemia Group B (CALGB 30107)
|
Jahan, Thierry
|
|
2012
|
76 |
3 |
p. 393-396
4 p.
|
artikel
|
Tijdschrift beschrijving